Additionally, our survival data showed that the high expression of TP53, EGFR, NOS3 and IL1B in HNSCC patients exhibited a poor prognosis, which was consistent with the previous reports mentioned above. This evidence concerns the gene IL1B and head and neck squamous cell carcinoma.